Quick Answer
Solid Biosciences Inc. reported Net Income of -$117.22 million for fiscal year 2019.
Solid Biosciences Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2019 | -$117.22M | -56.7% |
| 2018 | -$74.80M | -43.5% |
| 2017 | -$52.12M | -142.0% |
| 2016 | -$21.54M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | -$17.98M | +15.4% | +3.8% |
| June 30, 2021 | -$18.70M | +1.5% | -10.6% |
| March 31, 2021 | -$16.90M | +36.7% | +20.5% |
| September 30, 2020 | -$21.25M | +27.4% | -11.9% |
| June 30, 2020 | -$18.99M | +28.4% | +28.9% |
| March 31, 2020 | -$26.69M | +9.8% | +8.8% |
| September 30, 2019 | -$29.25M | -53.8% | -10.3% |
| June 30, 2019 | -$26.52M | -47.5% | +10.3% |
- Solid Biosciences Inc. showed a decrease of -56.7% in Net Income compared to the prior fiscal year.
- Over the 2016–2019 period, Solid Biosciences Inc.’s net income has declined by 444.2% (from -$21.54 million to -$117.22 million).
- The most recent figure is from Solid Biosciences Inc.’s fiscal year 2019 report (Form 10-K), filed with the SEC on March 12, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: